ReviewSeminars in cancer biology2018

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.

Lais Osmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.